Inmunidad adaptativa inducida por Bacillus Calmette-Guérin y su relación con COVID-19

Inmunidad adaptativa inducida por Bacillus Calmette-Guérin y su relación con COVID-19

RESUMEN La COVID-19, causado por SARS-CoV-2, ha sido un factor preocupante de mortalidad a nivel mundial, por lo que se están desarrollando varios enfoques innovadores para frenar la propagación del SARS-CoV-2. En particular, BCG, vacuna contra la tuberculosis, se está considerando como una moda...

Full description

Bibliographic Details
Main Authors:	Pablo Ordóñez Andrade, Juan Antonio Coyago Iñiguez
Format:	Article
Language:	English
Published:	University of Medical Sciences of Central America 2023-09-01
Series:	Ciencia & Salud
Subjects:	vacuna BCG Calmette-Guerín Bacillus COVID-19 enfermedad viral SARS-CoV-2 efectos heterólogos de las vacunas
Online Access:	https://revistacienciaysalud.ac.cr/ojs/index.php/cienciaysalud/article/view/684

Similar Items

Breast abscess due to Bacillus Calmette-Guérin
by: Aurélien Dinh, et al.
Published: (2017-06-01)

The impact of Bacillus Calmette-Guérin (BCG) vaccination on the course of COVID-19
by: Jakub Krzysztof Gałązka
Published: (2022-10-01)

Bacillus Calmette-Guerin (BCG) infections following intravesical BCG immunotherapy: a systematic review protocol
by: Roberta Monardo, et al.
Published: (2025-01-01)

Bacillus Calmette–Guérin and Bladder Cancer
by: Azad H.A. Razack
Published: (2007-10-01)

Evolution of the Bacillus Calmette-Guérin scar Russia and Moreau strains in newborns: A brazilian cohort
by: Ramon Andrade de Souza, et al.
Published: (2023-08-01)

Lessons from Bacillus Calmette-Guérin: Harnessing Trained Immunity for Vaccine Development
by: Samuel T. Pasco, et al.
Published: (2020-09-01)

Establishment of an in vitro model of monocyte-like THP-1 cells for trained immunity induced by bacillus Calmette-Guérin
by: Jin-Chuan Xu, et al.
Published: (2024-04-01)

A single strain of Mycobacterium bovis bacillus Calmette-Guérin (BCG) grown in two different media evokes distinct humoral immune responses in mice
by: V.L. Petricevich, et al.
Published: (2001-01-01)

Beyond Tuberculosis: The Surprising Immunological Benefits of the Bacillus Calmette–Guérin (BCG) Vaccine in Infectious, Auto-Immune, and Inflammatory Diseases
by: Magdalena Jurczak, et al.
Published: (2025-02-01)

Grupo Técnico de Estudos do BCG em Câncer Vacina BCG (Bacillus Calmette-Guérin)
by: Humberto Torloni, et al.
Published: (2023-08-01)

DISSEMINATED BACILLUS-CALMETTE-GUÉRIN INFECTIONS AND PRIMARY IMMUNODEFICIENCY DISORDERS IN SINGAPORE: A SINGLE CENTER 15-YEAR RETROSPECTIVE REVIEW
by: Rina Yue Ling Ong, et al.
Published: (2020-08-01)

Disseminated Bacillus Calmette–Guérin (BCG) infection and acute exacerbation of interstitial pneumonitis: an autopsy case report and literature review
by: Gen Shimizu, et al.
Published: (2020-09-01)

Effects of Bacillus Calmette-Guérin on immunometabolism, microbiome and liver diseases
by: Muhammad Umair Ijaz, et al.
Published: (2023-06-01)

Mycobacterium bovis Osteomyelitis of the Thoracic Spine Mimicking a Metastatic Lytic Lesion in a Patient Exposed to Intravesicular Bacille Calmette-Guérin Treatment
by: Jessica R. Newman, et al.
Published: (2014-07-01)

Impact of intravesical Bacillus Calmette-Guérin and chemotherapy on the bladder microbiome in patients with non-muscle invasive bladder cancer
by: Christopher James, et al.
Published: (2023-04-01)

Peripheral Mechanisms Underlying Bacillus Calmette–Guerin-Induced Lower Urinary Tract Symptoms (LUTS)
by: Meera Elmasri, et al.
Published: (2024-11-01)

Defined Antigen Skin Test for Bovine Tuberculosis Retains Specificity on Revaccination With Bacillus Calmette–Guérin
by: Saraswathi Subramanian, et al.
Published: (2022-04-01)

Genetic and Clinical Profiles of Disseminated Bacillus Calmette-Guérin Disease and Chronic Granulomatous Disease in China
by: Tao Li, et al.
Published: (2019-01-01)

Adverse reactions due to the bacillus Calmette-Guerin vaccine: Twenty Tunisian cases
by: Khadija Sellami, et al.
Published: (2018-01-01)

Measles infection causing Bacillus Calmette-Guérin reactivation: a case report
by: Sobana Muthuvelu, et al.
Published: (2019-07-01)

DIAGNOSTIC VALUE OF THE REACTION AT THE BACILLUS CALMETTE-GUÉRIN VACCINATION SITE IN KAWASAKI DISEASE
by: Lilian Martins Oliveira Diniz, et al.
Published: (2020-08-01)

Fibrosing mediastinitis in a child with Mendelian susceptibility to mycobacterial disease possibly due to Bacillus Calmette-Guérin
by: Niusha Sharifinejad, et al.
Published: (2022-11-01)

Bacillus calmette–Guérin scar inflammation after COVID vaccination
by: B N Shiva Prasad
Published: (2022-01-01)

Childhood lupus vulgaris after Bacillus Calmette–Guérin vaccine
by: Sarah Hamdy Soliman, et al.
Published: (2023-01-01)

Infección diseminada por vacuna con bacilo de Calmette-Guérin y coinfección por SARS-CoV-2 en paciente con deficiencia de la subunidad β1 del receptor de IL-12
by: Jesús Gerardo Allen-Manzur, et al.
Published: (2021-02-01)

Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette–Guérin vaccination against tuberculosis
by: I Abubakar, et al.
Published: (2013-09-01)

Single course of intravesical Bacillus Calmette–Guerin versus single course with maintenance therapy in the management of nonmuscle invasive bladder cancer: A prospective randomized study
by: Mohamed Bakr Mohamed, et al.
Published: (2020-01-01)

Granulomatous Hepatitis Following Intra-Vesical Instillation of Bacillus Calmette–Guérin for Treatment of Bladder Cancer
by: Elsa Alves Branco, et al.
Published: (2021-07-01)

Parapharyngeal tuberculoid mass: A rare complication of Bacillus Calmette‐Guérin therapy for urothelial carcinoma in situ
by: Karolina A. Plonowska‐Hirschfeld, et al.
Published: (2021-06-01)

Intravesical Bacillus Calmette-Guerin for Treatment of Refractory Interstitial Cystitis
by: Saeed Arasteh, et al.
Published: (2007-02-01)

Bacillus Calmette-Guerin Increases Base Excision Repair in Bladder Cancer Cells
by: Selçuk Keskin, et al.
Published: (2021-03-01)

Dual Bacillus Calmette–Guerin vaccination along the border communities of Angola and Namibia
by: Abubakar Sadiq Umar, et al.
Published: (2016-01-01)

New-onset guttate psoriasis following intravesical immunotherapy of Bacillus Calmette–Guerin
by: Chih-Tsung Hung, et al.
Published: (2012-09-01)

Ten Years' Experience with the Discontinuation of the Bacillus Calmette–Guérin Vaccination in the Czech Republic
by: Karolína Dolezalová, et al.
Published: (2021-01-01)

Bacillus Calmette-Guérin pneumonitis after intravesical instillation: Report of two cases and a review of the literature
by: Martina Spisarova, et al.
Published: (2024-06-01)

Intralesional Avirulent Bacillus Calmette-Guérin Injection as a Promising Method for the Treatment of Tuberculosis Verrucosa Cutis
by: Özgür Gündüz, et al.
Published: (2022-03-01)

Delayed Diagnosis of Mycobacterium bovis bacillus Calmette-Guérin Periprosthetic Joint Infection Following Total Knee Arthroplasty
by: Christopher E. Pelt, MD, et al.
Published: (2024-06-01)

Intravesical Bacillus Calmette-Guérin (BCG) treatment's severe complications: A single institution review of incidence, presentation and treatment outcome
by: R. Waked, et al.
Published: (2020-05-01)

Bacillus Calmette-Guérin Cases Reported to the National Tuberculosis Surveillance System, United States, 2004–2015
by: Zimy Wansaula, et al.
Published: (2019-03-01)

Successful treatment of anogenital warts with single dose Bacillus Calmette Guerin vaccine without prior sensitization in tuberculosis endemic country: Two case report
by: Pati Aji Achdiat, et al.
Published: (2023-01-01)